Wilson, DO, A. “PCSK9 Inhibitors, The Most Significant Advance in Lipid Lowering Therapy Since Statins? A Literature Review”. Osteopathic Family Physician, Vol. 11, no. 4, July 2019, https://ofpjournal.com/index.php/ofp/article/view/585.